GEODE CAPITAL MANAGEMENT, LLC - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q1 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.9%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q1 2020$17,000
-52.8%
45,429
-50.0%
0.00%
Q4 2019$36,000
-60.0%
90,858
+100.0%
0.00%
Q3 2019$90,000
-8.2%
45,4290.0%0.00%
Q2 2019$98,000
-7.5%
45,429
+34.4%
0.00%
Q1 2019$106,000
-36.9%
33,798
-50.0%
0.00%
Q4 2018$168,000
+24.4%
67,596
+100.0%
0.00%
Q3 2018$135,000
+7.1%
33,7980.0%0.00%
Q2 2018$126,00033,7980.00%
Other shareholders
CORREVIO PHARMA CORP shareholders Q1 2019
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders